Loading...
XIDX
RSGK
Market cap50mUSD
Jan 30, Last price  
980.00IDR
Name

Kedoya Adyaraya Tbk PT

Chart & Performance

D1W1MN
XIDX:RSGK chart
P/E
26.40
P/S
1.94
EPS
37.12
Div Yield, %
1.12%
Shrs. gr., 5y
-14.59%
Rev. gr., 5y
9.75%
Revenues
469.59b
+6.47%
242,988,383,688284,703,789,856294,916,939,542435,196,072,386359,156,149,470373,399,870,743441,072,474,000469,592,693,000
Net income
34.51b
-13.06%
12,722,869,1753,935,843,1182,615,905,33652,908,528,28126,179,899,83525,188,835,60439,692,367,00034,507,059,000
CFO
90.25b
+10.32%
12,722,869,1753,417,830,74322,266,936,96685,540,650,68768,277,280,28728,180,613,02181,804,569,00090,246,004,000
Dividend
Jun 24, 202411 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PT Kedoya Adyaraya Tbk operates as an Indonesian healthcare enterprise, managing and owning hospitals throughout the country. The company delivers a broad spectrum of medical services across numerous specialties, encompassing comprehensive surgical procedures such as general, orthopedic, urological, cardiothoracic, plastic, and neurological operations. It also provides internal medicine subspecialties like nephrology, endocrinology, and general internal medicine, alongside care in obstetrics and gynecology, cardiology, neurology, pulmonology, ophthalmology, hyperbaric medicine, and pediatrics. Additional services include acupuncture, medical rehabilitation, and speech therapy. Oral health is addressed through oral and maxillofacial services, prosthodontics, and general dentistry. Furthermore, mental health support is provided by psychiatrists and psychologists, nutritional guidance by dietitians, and specialized treatment for skin and venereal conditions. Beyond these specialized areas, the company also offers general medical care. As of December 31, 2021, PT Kedoya Adyaraya Tbk operated two hospitals, offering a combined capacity of 200 patient beds. Established in 1990, the company's main office is located in Jakarta Barat, Indonesia, and it functions as a subsidiary of PT Sarana Meditama Metropolitan Tbk.
IPO date
Sep 08, 2021
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT